Stone JA, Willey JZ, Keyrouz S, Butera J, McTaggart RA, Cutting S, Silver B, Thompson B, Furie KL, Yaghi S. Therapies for hemorrhagic transformation in acute ischemic stroke. Curr Treat Options Neurol. 146. Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, del Zoppo GJ, Kumar MA, Peerschke EI, Stiefel MF, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 147. Foster-Goldman A, McCarthy D. Angioedema from recombinant TPA administration: case report and pathophysiology review. Am J Ther. Powers et al 2019 Guidelines for Management of AIS e407 148. Gorski EM, Schmidt MJ. Orolingual angioedema with alteplase ad- ministration for treatment of acute ischemic stroke. J Emerg Med. 149. Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013;45:789 796. doi: 150. Lin SY, Tang SC, Tsai LK, Yeh SJ, Hsiao YJ, Chen YW, Chen KH, Yip BS, Shen LJ, Wu FL, et al. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angioten- sin-converting enzyme inhibitor use. Eur J Neurol. 2014;21:1285 1291. 151. Correia AS, Matias G, Calado S, Louren o A, Viana-Baptista M. Orolingual angiodema associated with alteplase treat- ment of acute stroke: a reappraisal. J Stroke Cerebrovasc Dis. 2015;24:31 152. O Carroll CB, Aguilar MI. Management of postthrombolysis hemor- rhagic and orolingual angioedema complications. Neurohospitalist. 153. Myslimi F, Caparros F, Dequatre-Ponchelle N, Moulin S, Gautier S, Girardie P, Cordonnier C, Bordet R, Leys D. Orolingual angioedema dur- ing or after thrombolysis for cerebral ischemia. Stroke. 2016;47:1825 154. Pahs L, Droege C, Kneale H, Pancioli A. A novel approach to the treatment of orolingual angioedema after tissue plasminogen ac- tivator administration. Ann Emerg Med. 